How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Reverse: 1999 is a gacha game. Players will pull from active Banners that offer a selection of featured characters ranging in rarity. The rarity of these characters is typically tethered to their ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

First, a few apologies. You will have seen little mention in these pages of arguably the most significant cinematic phenomenon of 2025. Ne Zha 2, a Chinese animated epic, did open (very quietly) in ...

In other recent news, Recursion Pharmaceuticals reported its third-quarter 2025 earnings, showcasing a mixed financial performance. The company’s earnings per share (EPS) were -$0.36, slightly beating ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Angelica Leicht is a seasoned personal finance writer and editor with nearly two decades of experience but just one goal: to help readers make the best decisions for their wallets. Her expertise spans ...

Your support goes further this holiday season. When you buy an annual membership or give a one-time contribution, we’ll give a membership to someone who can’t afford access. It’s a simple way for you ...

A reverse mortgage allows seniors to access cash from the equity they've built up in their homes. Unlike home equity loans or HELOCs, there's usually no credit score requirement and you don't have to ...